Delta Variant: Expanding the Indication for Eluxadoline to Bile Acid Diarrhea

Dig Dis Sci. 2022 Aug;67(8):3481-3482. doi: 10.1007/s10620-022-07386-y. Epub 2022 Feb 5.

Author

Affiliation

¹ Center for Gastrointestinal Motility, Esophageal, and Swallowing Disorders, Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH, 03766, USA. eric.d.shah@hitchcock.org.

PMID: 35122590
DOI: 10.1007/s10620-022-07386-y

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Bile Acids and Salts*
Diarrhea / drug therapy
Diarrhea / etiology
Gastrointestinal Agents / therapeutic use
Humans
Imidazoles / therapeutic use
Irritable Bowel Syndrome* / drug therapy
Phenylalanine / analogs & derivatives
Phenylalanine / therapeutic use

Substances

Bile Acids and Salts
Gastrointestinal Agents
Imidazoles
eluxadoline
Phenylalanine